We are live on ! Find out more
SNOA icon

Sonoma Pharmaceuticals
SNOA

14 hedge funds and large institutions have $27.3K invested in Sonoma Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.06% less ownership

Funds ownership: 0.11% → 0.05% (-0.06%)

13% less funds holding

Funds holding: 16 → 14 (-2)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

50% less capital invested

Capital invested by funds: $54.8K → $27.3K (-$27.5K)

Holders
14
Holders Change
-2
Holders Change %
-12.5%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$7.43K
2
XT
XTX Topco
Cayman Islands
+$2.66K
3
TSS
Two Sigma Securities
New York
+$2.18K
4
TRCT
Tower Research Capital (TRC)
New York
+$397
5
Wells Fargo
Wells Fargo
California
+$3

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$21.1K
2
JP Morgan Chase
JP Morgan Chase
New York
-$5.96K
3
HF
HRT Financial
New York
-$5K
4
Millennium Management
Millennium Management
New York
-$3.05K
5
Goldman Sachs
Goldman Sachs
New York
-$1.82K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$7.66K +$7.43K +2,303 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$5.95K – – –
State Street
3
State Street
Massachusetts
$4.04K – – –
XT
4
XTX Topco
Cayman Islands
$2.74K +$2.66K +823 New
TSS
5
Two Sigma Securities
New York
$2.24K +$2.18K +674 New
Millennium Management
6
Millennium Management
New York
$2.17K -$3.05K -944 -59%
TRCT
7
Tower Research Capital (TRC)
New York
$1.99K +$397 +123 +26%
BlackRock
8
BlackRock
New York
$377 – – –
US Bancorp
9
US Bancorp
Minnesota
$83 – – –
Wells Fargo
10
Wells Fargo
California
$20 +$3 +1 +20%
UBS Group
11
UBS Group
Switzerland
$17 -$1.43K -442 -99%
Morgan Stanley
12
Morgan Stanley
New York
$14 -$16 -5 -56%
AF
13
Allworth Financial
California
$11 – – –
Bank of America
14
Bank of America
North Carolina
$7 – – –
Citadel Advisors
15
Citadel Advisors
Florida
– -$21.1K -5,839 Closed
JP Morgan Chase
16
JP Morgan Chase
New York
– -$5.96K -1,652 Closed
HF
17
HRT Financial
New York
– -$5K -1,393 Closed
Goldman Sachs
18
Goldman Sachs
New York
– -$1.82K -506 Closed
ASN
19
Advisory Services Network
Georgia
– -$444 -123 Closed

SNOA Hedge Fund Activity: Q1 2024 in Review

14 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q1 2024, worth a combined $27.3K — down 50% from $54.8K a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of SNOA and 3 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $7.43K. The largest seller was Citadel Advisors, exiting entirely with an estimated $21.1K sold.

  • 14 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q1 2024, down from 16 in Q4 2023.
  • Funds reported $27.3K of Sonoma Pharmaceuticals stock for Q1 2024, down 50% quarter-over-quarter.
  • 3 funds opened new Sonoma Pharmaceuticals positions in Q1 2024 and 5 closed out, a net change of -2 holders.
  • The largest Sonoma Pharmaceuticals buyer in Q1 2024 was Susquehanna International Group, an estimated $7.43K added.
  • The largest Sonoma Pharmaceuticals seller in Q1 2024 was Citadel Advisors, an estimated $21.1K sold.

Based on aggregated 13F filings for Q1 2024.